{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:02:45Z","timestamp":1791291765194,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":7650,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1034\/j.1600-6143.2002.020109.x","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T20:37:05Z","timestamp":1047328625000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy"],"prefix":"10.1016","volume":"2","author":[{"given":"Yvon","family":"Lebranchu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bridoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick Le","family":"Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Toupance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Hurault de","family":"Ligny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Le Pogamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Reigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Guignard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Rifle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1034\/j.1600-6143.2002.020109.x_bib1","series-title":"Monoclonal Antibodies in Transplantation","first-page":"53","article-title":"The clinical and experimental use of monoclonal antibodies to the IL-2 receptor","author":"Amlot","year":"1995"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00007890-198812000-00001","article-title":"Interleukin-2 receptor-targeted therapy \u2013 rationale and application in organ transplantation","volume":"46","author":"Kupiec-Weglinski","year":"1988","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib3","first-page":"283","article-title":"Immunosuppressive agents in clinical trials in transplantation","volume":"313","author":"Halloran","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00003495-199651050-00010","article-title":"Muronomab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection","volume":"51","author":"Wilde","year":"1996","journal-title":"Drugs"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib5","first-page":"435","article-title":"Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3","volume":"15","author":"Bonnefoy-Berard","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0272-6386(96)90297-8","article-title":"Immunosuppressants: cellular and molecular mechanisms of action","volume":"28","author":"Suthanthiran","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.7326\/0003-4819-128-10-199805150-00011","article-title":"Antilymphocyte antibodies, renal transplantation, and meta-analysis (editorial)","volume":"128","author":"Levey","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib8","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1681\/ASN.V8111771","article-title":"Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis","volume":"8","author":"Szczech","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-128-10-199805150-00004","article-title":"The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data","volume":"128","author":"Szczech","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of Thymoglobulin versus ATGAM for induction immunosuppressive therapy in adult renal transplant recipients","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00007890-198802000-00032","article-title":"Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function","volume":"45","author":"Matas","year":"1988","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00007890-198911000-00016","article-title":"A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients","volume":"48","author":"Michael","year":"1989","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ki.1996.106","article-title":"OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival","volume":"49","author":"Abramowicz","year":"1996","journal-title":"Kidney Int"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJM199004263221702","article-title":"Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts","volume":"322","author":"Soulillou","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00007890-199510150-00023","article-title":"Prolonged action of a chimeric interleukin-2 receptor (CD 25) monoclonal antibody used in cadaveric renal transplantation","volume":"60","author":"Amlot","year":"1995","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib16","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/00007890-199712270-00012","article-title":"Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts","volume":"64","author":"Kovarik","year":"1997","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib17","first-page":"913","article-title":"Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD 25) monoclonal antibody SDZ CHI 621 in renal transplantation","volume":"28","author":"Kovarik","year":"1996","journal-title":"Transplant Proc"},{"issue":"Suppl. 1","key":"10.1034\/j.1600-6143.2002.020109.x_bib18","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/j.1432-2277.1996.tb01641.x","article-title":"Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients","volume":"9","author":"Kovarik","year":"1996","journal-title":"Transplant Int"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib19","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of cellular rejection in renal allograft recipients","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin 2 receptor monoclonal antibody","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib21","doi-asserted-by":"crossref","unstructured":"European Mycophenolate Mofetil Cooperative Study Group. Placebocontrolled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-1325.","DOI":"10.1016\/S0140-6736(95)92534-1"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/00007890-200010150-00018","article-title":"Increased impact of acute rejection on chronic allograft failure in recent era","volume":"70","author":"Meier-Kriesche","year":"2000","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00007890-200011150-00015","article-title":"Double blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection","volume":"70","author":"Vanrenterghem","year":"2000","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","article-title":"Induction versus non induction in renal transplant recipients with tacrolimus\u2013based immunosuppression","volume":"72","author":"Mourad","year":"2001","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib25","unstructured":"Sollinger H, Kaplan B, Pescovitz M et al. A multicenter, randomized trial of Simulect with early Neoral vs Atgam with delayed Neoral in renal transplantation. A 6 month interim analysis. Transplantation 2001, in press."},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"on behalf of the \u2018\u2019Simulect\u00d2 Phase IV Study Group. A randomized double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin 2 receptor blockade with daclizumab to prevent acute rejection in renal transplantaton. Daclizumab triple therapy Study Group","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib28","unstructured":"Lawen J, Davies EA, Mourad G et al. on behalf of the Simulect InternationalStudy Group. Randomized double blind study of immunoprophylaxis with basiliximab, a chimeric anti-IL-2R monoclonal antibody, with MMF containing triple therapy in renal transplantation. Transplantation 2001, in press."},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0041-1345(99)00992-6","article-title":"Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine and Cellcept? One year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids","volume":"32","author":"Lebranchu","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199201000-00011","article-title":"Analyses of the UNOS Scientific Renal Transplant Registry at three years early events affecting transplant success","volume":"53","author":"Cecka","year":"1992","journal-title":"Transplantation"},{"issue":"Suppl. 1","key":"10.1034\/j.1600-6143.2002.020109.x_bib31","first-page":"27","article-title":"Cytokine nephropathy during antilymphocyte therapy","volume":"25","author":"Batiuk","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1034\/j.1600-6143.2002.020109.x_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0041-1345(99)00975-6","article-title":"The use of Thymoglobuline induction in renal transplantation: a pharmacovigilance study","volume":"32","author":"Hurault de Ligny","year":"2000","journal-title":"Transplant Proc"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.020109.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.020109.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352207054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352207054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-6143.2002.020109.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:25:24Z","timestamp":1761625524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352207054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S160061352207054X"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.020109.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.020109.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}